SERVIER PARTNERS WITH BIOLABS TO OPEN AN INCUBATOR IN PARIS-SACLAY FOR EARLY STAGE LIFE SCIENCE START-UPS
14/10/2021
Our News
21400
employees
100 million
patients treated each day
worldwide
with Servier medicines.
+20％
of our turnover,
excluding generics,
is reinvested in R&D.
€4.9 billion euros
in revenue comprising €3.7 billion
for brand-name medicines
€1.2 billion for generic medicines.
4 therapeutic areas
oncology, cardiometabolism
neuroscience and
immuno-inflammation
Servier Medical Art is a medical image bank that we make available to illustrate your medical releases.
OUR COMMITMENTS
Above all, we believe in our profession!
We are a research-based organisation. We are focused on the future and on useful discoveries.
All our activities are based on three key principles.